
With the recent introduction of the Thermo Scientific Stellar mass spectrometer, a new paradigm for targeted quantitation has been introduced to greatly expand the number of peptides quantified in a targeted quantitative method, achieving higher LOQs using faster liquid chromatographic gradients.
This live webinar will provide a detailed discussion on the new hardware and software innovations delivering the new performance that, when coupled with low-flow UHPLC systems, forms a powerful verification-class LC-MSn solution. Translational research results will be presented on biomarker development studies for cancer, neurodegenerative disorders and amyloidosis.
You will learn:
• How to extend plasma proteome coverage using new enrichment strategies and new mass spectrometers for discovery
• How to efficiently and effectively transfer discovery-based plasma proteins for robust targeted quantitative analysis
• The analytical capabilities of a novel hybrid nominal mass resolution tandem mass spectrometer






Πρέπει να έχετε συνδεθεί για να σχολιάσετε.